Medical Research
Research Development & Innovation
Mission
The Research, Development, and Innovation department specializes in the development of specialized research programs in biotechnology. Research scientists employ both traditional and cutting-edge biotechnologies to develop innovative products for national development.
To lead Zimbabwe into a sustainable future by harnessing biotechnological innovations in agriculture, medicine, and environmental stewardship.
Join us in advancing crop, medical, pharmaceutical, environmental, and animal biotechnology. Ensure biosafety, manage the National Biosafety Reference Laboratory, register products, administer the Biotechnology Fund, and respond to grants and publications with us.
Innovating Biotechnology for a Sustainable Future
Our Solutions
Manage the National Biosafety Reference Laboratory, register products, administer the Biotechnology Fund, and secure grants with us.
-
-
Crop Improvement
-
Biosafety Research
-
Product Registrations
-
Grant Responses
Genomics Center
The initial focus of the Genomic Centre is to advance scientific and technological competencies in genomics technologies. This includes genome and gene sequencing, gene annotation, editing, and expression, as well as forensics and diagnostics. Additionally, the Centre will develop and apply bioinformatics solutions.
Products Manufacturing
Biotechnology can transform the Zimbabwean economy, unlocking immense potential in agriculture, medicine, and environmental management. By embracing biotechnology, Zimbabwe can leapfrog into advanced modernization, driving socio-economic progress and sustainable development. Globally, the biotechnology industry has seen rapid growth, highlighting its critical role in future innovations and economic advancement.
Sample Testing
We facilitate research and innovation through sample testing and tissue culture for root and tuber crops. Our focus includes improving yields of food crops like maize and potatoes, and cash crops such as cotton and soybeans, as well as bioremediation of contaminated sites. Additionally, we develop human and animal medicines, promote industrial genomic technologies, and convert research into commercially viable, patentable products.